Your browser doesn't support javascript.
loading
Reducing Kidney Disease Burden in Type 2 Diabetes with SGLT2 Inhibitors: Shifting the Goalposts Upstream.
Rangaswami, Janani; Mathew, Roy O.
Affiliation
  • Rangaswami J; George Washington University School of Medicine , Washington, DC.
  • Mathew RO; VA Medical Center , Washington, DC.
Clin J Am Soc Nephrol ; 18(9): 1119-1121, 2023 09 01.
Article in En | MEDLINE | ID: mdl-37498620
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Kidney Diseases Limits: Humans Language: En Journal: Clin J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Kidney Diseases Limits: Humans Language: En Journal: Clin J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2023 Document type: Article Country of publication: